Mithra Pharmaceuticals S.A.
MITPF · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $1 | $1 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $1 | $1 | $1 | $1 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -40.1% | 195.6% | 151% | – |
| Gross Profit | $0 | $0 | -$0 | -$0 |
| % Margin | 14.9% | 52.9% | -15.4% | -47.6% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | -131.4% | 26.1% | -362.9% | -890.1% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -432.1% | -89% | -515.6% | -1,019.8% |
| EPS Diluted | -2.51 | -1.22 | -2.69 | -2.25 |
| % Growth | -105.7% | 54.6% | -19.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |